CB2 Insights Completes Purchase of Colorado-based Relaxed Clarity with Surpassed Initial Targets and Provides Additional Corporate Updates
Cannabis Investing CB2 Insights Announces Delay in Filing Under CSA Instrument Governing Relief Under COVID-19 Duress
Cannabis Investing CB2 Insights Launches Industry’s First Medical Cannabis Insights Dashboard for All Medical Cannabis Stakeholders
Cannabis Investing Orchid Ventures Announces The Launch Of A New Subsidiary, PurTec Delivery Systems, A Delivery System Technology Company
Cannabis Investing CB2 Insights Appoints Healthcare Industry Expert and Former IQVIA Executive Tom Brogan to its Board of Directors
Cannabis Investing CB2 Insights Announces Industry’s First Full-Scale Hemp-based Cannabidiol (CBD) Prospective Trial in Partnership with GL Brands (Formerly Freedom Leaf Inc.)
Cannabis Investing CB2 Insights Announces Collaboration with FCM Global to Support Medical Cannabis R&D in Colombia
Cannabis Investing Orchid Ventures Releases a Letter from the CEO and Announces Upcoming Shareholder Meeting
Cannabis Investing Orchid Ventures CEO Responds to Oregon Court of Appeals Stay on the Ban of Flavored Cannabis Vape Products
Brunswick Exploration Announces Brokered Private Placement for Gross Proceeds of up to C$2.5 Million, with a Lead Order from a Strategic Investor
RETRANSMISSION: Group Eleven to be Featured on Radius Research for a Live Company Pitch, Deep Dive and Q&A Webinar
